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Introduction
Porcine reproductive and respiratory syndrome (PRRS), 
characterized by reproductive failure in pregnant sows and 
respiratory disease in piglets,29 has a major economic impact 
on the pig industry worldwide. The causative agent is an 
enveloped positive-strand RNA virus (order Nidovirales, 
family Arteriviridae, genus Arterivirus4) that was first iso-
lated in the Netherlands.38 The genome of the PRRS virus 
(PRRSV) is organized in 9 open reading frames (ORFs) cod-
ing for the viral replicase (ORF1a and 1b), 4 membrane-
associated glycoproteins (ORFs 2a–5), 2 unglycosylated 
membrane proteins (ORF2b and ORF6), a polypeptide 
termed ORF5a protein, and the nucleocapsid protein 
(ORF7).6,14,19,20,40 PRRSV isolates are classified into 2 geno-
types, the European (EU, genotype 1 [EU]) and the North 
American (NA, genotype 2 [NA]).22 Although inducing the 
same disease symptoms, both genotypes are antigenically 
and genetically very different.16,28 Even within the EU gen-
otype, originally thought to form a more homogeneous 
group,38 a high genetic diversity was demonstrated.7,9,25,32,35 
The classification of EU genotype PRRSV into 4 subtypes 
has been suggested recently.30,31
For the detection of the highly variable PRRSV genome, 
different commercial kits as well as a variety of published 
reverse transcription polymerase chain reactions (RT-PCR) 
and real-time RT quantitative PCR (RT-qPCR) systems are 
available. Previously described assays are either suitable for 
pan-PRRSV detection2 or they are designed to differentiate 
between the EU and the NA genotype. This differentiation 
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Abstract. To compare the real-time reverse transcription quantitative polymerase chain reaction (RT-qPCR) assays used 
for the diagnosis of Porcine reproductive and respiratory syndrome virus (PRRSV), a Europe-wide interlaboratory ring trial 
was conducted. A variety of PRRSV strains including North American (NA) and European (EU) genotype isolates were 
analyzed by the participants. Great differences regarding qualitative diagnostics as well as analytical sensitivity were observed 
between the individual RT-qPCR systems, especially when investigating strains from the EU genotype. None of the assays 
or commercial kits used in the ring trial could identify all different PRRSV strains with an optimal analytical and diagnostic 
sensitivity. The genetic variability of the PRRSV strains, which is supposed to hinder the diagnostic of the RT-PCR because 
of mutations at the primer binding sites, was also confirmed by sequencing and subsequent phylogenetic analysis. In summary, 
a major problem in PRRSV diagnostics by RT-qPCR is false-negative results. To achieve maximum safety in the molecular 
diagnosis of PRRSV, the combined usage of different assays or kits is highly recommended.
Key words: Polymerase chain reaction; Porcine reproductive and respiratory syndrome virus.
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is possible in a single multiplex amplification8,17,26 or in 2 
separate reactions.27 Furthermore, there are RT-PCR assays 
for the specific genotype detection available.1,31 Beside these 
published RT-PCR assays, several commercial kits for 
the genome detection and differentiation of PRRSV are 
available.
The aim of the current study was a comparative assessment 
of the wide range of assays (in-house and commercial test sys-
tems) used in different European laboratories. Using a variety 
of PRRSV EU and NA strains, the suitability of these assays 
for a reliable PRRSV genome detection was investigated.
Materials and methods
PRRSV isolates and diagnostic samples
The PRRSV strains used in the current study were obtained 
from the virus collection of the Friedrich-Loeffler-Institut, 
Isle of Riems, Germany or were kindly provided by T. Stadejek, 
National Veterinary Research Institute, Poland. Designation, 
collection date, and country of the strains are summarized in 
Table 1. RNA was manually extracteda according to the 
manufacturer’s recommendations and diluted in RNA 
extracted from blood of PRRSV-negative swine. Two log
10 
dilution series of EU strains and 1 NA-HP (highly patho-
genic) strain were prepared; 7 additional EU strains, at least 
1 of each subtype, and 3 NA strains were also integrated in 
the panel. Finally, 3 negative samples were added. The 28 
samples were randomly coded and sent to each of the 7 par-
ticipating laboratories on dry ice. In addition to these ring 
trial samples, diagnostic lung specimens, kindly provided by 
German veterinary laboratories, were further studied using 
the commercial RT-qPCR kits.
Real-time RT-PCR
In the 7 participating laboratories, a total of 4 different com-
mercially available RT-qPCR kits (I–IV) and 8 in-house 
assays (Table 2) were used. The applied commercial kits 
Table 1. Identity of the 28 Porcine reproductive and respiratory syndrome virus RNA samples used in the ring trial.*
GenBank accession no.
Sample Strain Country Year Dilution Genotype-Subtype ORF5 ORF6 ORF7
 1 Stendal V953 (no. x134) Germany 1996 1.00E-02 EU-1 JN651728 JN651709 JN651690
 2 Stendal V953 (no. x134) 1.00E-03  
 3 Stendal V953 (no. x134) 1.00E-04  
 4 Stendal V953 (no. x134) 1.00E-05  
 5 Stendal V953 (no. x134) 1.00E-06  
 6 Stendal V1952/97 (no. x151) Germany 1997 1.00E-02 EU-1 JN651729 JN651710 JN651691
 7 Stendal V1952/97 (no. x151) 1.00E-03  
 8 Stendal V1952/97 (no. x151) 1.00E-04  
 9 Stendal V1952/97 (no. x151) 1.00E-05  
10 Stendal V1952/97 (no. x151) 1.00E-06  
11 Cobbelsdorf (no. 210) Germany 1991 1/500 EU-1 JN651730 JN651711 JN651692
12 Stendal V852 (no. x133) Germany 1996 1/500 EU-1 JN651731 JN651712 JN651693
13 Stendal V1904 (no. x135) Germany 1996 1/500 EU-1 JN651732 JN651713 JN651694
14 Aus Lithuania 2002 1/10 EU-2 JN651733 JN651714 JN651695
15 Bor Belarus 2009 1/10 EU-2 JN651734 JN651715 JN651696
16 Sza Belarus 2010 1/10 EU-3 JN651735 JN651716 JN651697
17 OKT Belarus 2010 1/10 EU-4 JN651736 JN651717 JN651698
18 China (no. 581) China 2008 1.00E-02 NA JN651741 JN651722 JN651703
19 China (no. 581) 1.00E-03  
20 China (no. 581) 1.00E-04  
21 China (no. 581) 1.00E-05  
22 China (no. 581) 1.00E-06  
23 Stendal V1445/99 (no. x155) Germany 1999 1/500 NA JN651742 JN651723 JN651704
24 USA VD29949/17 (no. 441) USA Unknown 1/500 NA JN651743 JN651724 JN651705
25 USA 2 (no. 244) USA 1990 1/500 NA JN651744 JN651725 JN651706
26 Negative swine sample  
27 Negative swine sample  
28 RSB 50  
* The registration numbers of the respective stains within the virus collection of the Friedrich-Loeffler-Institut (Insel Riems, Germany) are given in 
parentheses. GenBank accession numbers indicate the sequences generated in the current study. EU = Europe; NA = North America; ORF = open reading 
frame.
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varied regarding total reaction volume (kit I: 20 µl, kits II–IV: 
25 µl) and template volume (IV: 4-µl kit, I+II: 5 µl, III: 8 µl). 
Kits I and II have been used by 1 of the participating labora-
tories and kits III and IV by 3 laboratories.
A part of the in-house RT-qPCR systems were used as 
described previously,8,17,27 while individual modifications 
were integrated in other assays.2,17,23,33 In 5 out of 7 laborato-
ries, the samples were tested by more than 1 assay. Previously 
described systems8,17 as well as 3 of the commercial kits 
enable genotype differentiation in a single reaction; a previ-
ously described assay27 and 1 of the commercial kits required 
for testing feature 2 separate reactions. One RT-qPCR sys-
tem(23,33 modified; Table 2) allows genotyping only after gel 
electrophoresis.
RNA extracted from German field lung samples was 
tested by the 4 commercial kits according to the manufac-
turer’s recommendations within a single laboratory. The 
presence of PRRSV genome was confirmed by sequencing.
Sequencing and phylogenetic analysis
ORFs 5, 6, and 7 of the PRRSV strains were sequenced using 
published primers,10,23,28 based on data obtained hereby alter-
native primers were designed (Table 3). The RT-PCR was 
carried out using a commercial PCR kit,b and the amplified 
products were separated on 2.0% agarose gels,c visualized by 
staining with ethidium bromide, and subsequently excised and 
purifiedd according to the manufacturer’s recommendations. 
Table 2. Sequences of primers and probes of the in-house assays used for Porcine reproductive and respiratory syndrome virus 
genome detection in the ring trial.*
Reference Forward primer Reverse primer Probe Genomic target
Kleiboeker et al.17 EU: GCACCACC 
TCACCCAGAC
EU: CAGTTCC 
TGCGCCTTGAT
EU: 6-FAM-
CCTCTGCTTGCAATC 
GATCCAGAC-BHQ1
ORF 7
 NA-1: ATGATGRG 
CTGGCATTCT
NA: ACACGGT 
CGCCCTAATTG
NA: Cy5-TGTGGTGAATGGC 
ACTGATTGACA-BHQ2
 
 NA-2: ATRATGR 
GCTGGCATTCC
 
Kleiboeker et al.17 
modified (1)
EU-1: GCACCAC 
CTCACCCRRAC
EU-1: CAGTTCCTG 
CRCCYTGAT
EU-1: 6-FAM-CCTCTGYYTG 
CAATCGATCCAGAC-BHQ1
ORF 6, ORF 7
 EU-2: CAGATGCAGAY 
TGTGTTGCCT
EU-2: TGGAGDCC 
TGCAGCACTTTC
EU-2: 6-FAM-ATACATTCTGG 
CCCCTGCCCAYCACGT-
BHQ1
 
 NA: ATRATGRG 
CTGGCATTC
NA: ACACGGTC 
GCCCTAATTG
NA: TEX-
TGTGGTGAATGGCA 
CTGATTGACA-BHQ2
ORF 7, 3’UTR
Kleiboeker et al.17 
modified (2)
EU: GATGACRTCCGGCAY EU: CAGTTCCTG 
CGCCTTGAT
EU: 6-FAM-TGCAATCGATC 
CAGACGGCTT-TAMRA
ORF 7, 3’UTR
 NA-1: ATGATGRG 
CTGGCATTCT
NA: ACACGGTC 
GCCCTAATTG
NA: HEX-TGTGGTGAATGG 
CACTGATTGACA-TAMRA
 
 NA-2: GTRATGRG 
CTGGCATTCC
 
Egli et al.8 TCAICTGTGICAGITGCTGG AAATGIGGCTTCT 
CIGGITTTTT
EU: 6-FAM-TCCCGGTCCCTT 
GCCTCTGGA-TAMRA
ORF 7
 NA: HEX-CCCAGCGCCAG 
CAACCTAGGG-BHQ1
 
Balka et al.2 
modified (1)
AGCCTCGTGYTG 
GGYGGCARA
(FAM)-TCAGCAWYTG 
RCACAGYTGAT
TCCGATGGGGAATGGCC 
AGCCAGTCT-(ATTO663)
ORF 6, ORF 7
Balka et al.2 
modified (2)
AGCCTCGTGYTGG 
GYGGCARA
(FAM)-TCAGCAWYTGRC 
ACAGYTGAT
[Contact author for sequence] ORF 6, ORF 7
Revilla-
Fernández27
EU: GTAGAAAGTGCT 
GCAGGTCTCCA
EU: CACGAGGCTCC 
GAAGTCCT
EU: 6-FAM-CTGTGAGA 
AAGCCCGGAC-NFQ-MGB
ORF 6
 NA: TCCAGATG 
CCGTTTGTGCTT
NA: GACGCCGGA 
CGACAAATG
NA: 6-FAM-CCCTGCC 
CACCACGT-NFQ-MGB
 
Suárez et al.33/
Oleksiewicz  
et al.23 modified
ATGGCCAGC 
CAGTCAATCA
TCGCCCTAATTG 
AATAGGTGACT
SYBR Green ORF 7, 3’UTR
* EU = Europe; NA = North America; ORF = open reading frame; UTR = untranslated region.
 at Tech Knowl Center - Inst 5500 on July 26, 2012vdi.sagepub.comDownloaded from 
4 Wernike et al.
Table 3. Primers used in the current study for sequencing.*
Position  
Primer Sequence 5’–3’ Lelystad virus VR-2332 Reference
PRRSV-EU-13373F CCCAACAYACMCAGCAGCA 13373 Current study
EU-ORF5 S(2)_F TGAGGTGGGCTACAACCATT 13400 Greiser-Wilke et al.10
EU/NA-ORF5 S_F CGGTTGCTICATTTCITGAC 13414 13694 Greiser-Wilke et al.10
EU-ORF5 S (1)_F CAATGAGGTGGGCIACAACC 13442 Oleksiewicz et al.23
PRRSV-EU-13915F CCCGGTTYACCAACTTCATTG 13915 Current study
PRRSV-EU-13929F TTCATTGTGGAYGACCGRGG 13929 Current study
PRRSV-EU-14072F GACTTCDGCYGAGCAATGG 14072 Current study
EU-ORF5 AS (2)_R AGGCTAGCACGAGCTTTTGT 14102 Greiser-Wilke et al.10
LV6F CGCCGCACAAAAGCTCGTGC 14122 Ropp et al.28
EU-ORF5 AS (1)_R TATGTIATGCTAAAGGCTAGCAC 14160 Oleksiewicz et al.23
EU/NA-ORF5 AS_R CACCTTIAGGGCITATATCA 14191 14482 Greiser-Wilke et al.10
PRRSV-EU-M-14374F CAGATGCAGAYTGTGTTGCCT 14374 Current study
EU/NA-ORF7 S_F GCCCCTGCCCAI CAC 14414 14705 Greiser-Wilke et al.10
PRRSV-EU-M-14451R TGGAGDCCTGCAGCACTTTC 14451 Current study
PRRSV-EU-M-14477F GCATACGCTGTGAGAAAGCC 14477 Current study
PRRSV-EU-M-14501R GTCCGGGCTTTCTCACAGC 14501 Current study
LV6R CGAGCTGTTAAACGAGGAGT 14580 Ropp et al.28
LV7F AACCTCGTCAAGTATGGCCG 14585 Ropp et al.28
Euro1R CGAGGTTAACCACTCCTCG 14592 Ropp et al.28
PRRSV-EU-14595R TTGACGAGGTTAACCACTCC 14595 Current study
PRRSV-EU-14605R CCGGCCATACTTRACGAGG 14605 Current study
LV56R CAATGATAAAGTCCCAGCGCA 14712 Ropp et al.28
PRRSV-EU-2.1R CAGTTCCTGCRCCYTGAT 14868 Current study
EU/NA-ORF7 AS_R TCGCCCTAATTGAATAGGTGA 15050 15364 Oleksiewicz et al.23
NA-ORF5 S_F GCTCCATTTCATGACACCTG 13699 Oleksiewicz et al.23
PRRSV-HF-14263F TAACCAGAGTTTCAGCGGAAC 14353 Current study
NA-ORF5 AS_R AAAGGTGCAGAAGCCCTAGC 14517 Oleksiewicz et al.23
PRRSV-HF-14869R TGGCACAGCTGATTGACTGG 14959 Current study
* The genome position according to Europe prototype strain Lelystad (accession no. M96262) and North America prototype strain VR-2332 (accession no. 
AY150564) represent the 5’ end of the primers.
Sequencing reactions of both strands with the primers used 
for amplification were carried out.e Subsequent sequence 
determination was performed,f and the obtained sequence 
data was assembled.g Sequence alignments, identification of 
ORFs, and calculation of similarity of the used strains to 
their respective prototype strains were supported by BioEdit 
software version 7.0.9.0.12 Sequences generated in the cur-
rent study were submitted to GenBank (accession numbers 
are given in Tables 1 and 6, respectively). Neighbor-joining 
trees were generated using the Kimura 2-parameter model 
with 1,000 bootstrap replicates as implemented in Mega 5.34 
In addition to the PRRSV strains used in the ring trial, a 
selection of reference sequences representing the global 
diversity of PRRSV was used for phylogenetic analysis 
(Table S1 in the supplementary materials). These reference 
sequences were selected from GenBank and comprise strains 
from Europe, Asia, and North America.
Results
Real-time RT-PCR
The results of the pan-PRRSV genome detection are out-
lined in Table 4 and of the genotype-specific assays in Table 5. 
Samples were defined as false negative if at least 50% of the 
assays produced a positive result, which means, for the pan-
PRRSV genome detection, that false-negative results were 
postulated if 8 or more assays gave a positive result. For 
PRRSV genotype-specific RT-qPCR detection, 7 positive 
results were necessary to define negative results of this 
RNA dilution as false negative. The NA-HP strain used as 
dilution series was detected correctly by all assays; how-
ever, the analytical sensitivity ranged from dilution step 
1.00E-03 to 1.00E-06. All of the other NA strains, with 
exception of “USA 2” in 1 assay, were also detected cor-
rectly. Every NA strain was classified into the NA genotype 
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Table 4. Mean quantification cycle (Cq) values of pan–Porcine reproductive and respiratory syndrome virus (PRRSV) genome 
detection submitted by the 7 participating laboratories using commercial reverse transcription quantitative polymerase chain reaction kits 
and in-house assays.*
Commercial kit
 Kit I Kit II Kit III Kit IV
Sample PRRSV strain Dilution Pan EU+NA EU+NA EU+NA EU+NA EU+NA EU+NA EU+NA
 1 Stendal V953 1.00E-02 30 27 23 27 25 29 27 28
 2 Stendal V953 1.00E-03 33 30 27 31 28 33 32 33
 3 Stendal V953 1.00E-04 36 33 30 34 32 38† No Cq 39
 4 Stendal V953 1.00E-05 38 36 33 No Cq 36 No Cq No Cq No Cq
 5 Stendal V953 1.00E-06 No Cq 41† 36† No Cq No Cq No Cq No Cq No Cq
 6 Stendal V1952/97 1.00E-02 30 25 22 25 23 27 23 24
 7 Stendal V1952/97 1.00E-03 33 28 25 29 27 28 26 26
 8 Stendal V1952/97 1.00E-04 36 32 29 32 30 32 29 30
 9 Stendal V1952/97 1.00E-05 40 35 32 33 33 36 33 34
10 Stendal V1952/97 1.00E-06 No Cq 39 35 37 36 No Cq No Cq 37
11 Cobbelsdorf 1:500 27 27 24 27 26 26 24 24
12 Stendal V852 1:500 28 27 26 29 27 28 25 26
13 Stendal V1904 1:500 28 28 23 27 25 28 26 27
14 Aus 1/10 No Cq 22 34 No Cq 33 22 20 21
15 Bor 1/10 No Cq 30 No Cq No Cq No Cq 28 26 27
16 SZA 1/10 No Cq 27 22 25 23 24 21 23
17 Okt 1/10 No Cq 30 36 No Cq 36 26 24 25
18 China 1.00E-02 28 28 23 23 24 23 21 22
19 China 1.00E-03 33 31 27 27 27 27 24 26
20 China 1.00E-04 35 34 30 30 31 30 27 29
21 China 1.00E-05 38 38 33 33 33 34 31 33
22 China 1.00E-06 No Cq No Cq 36 36 No Cq 37 34 37
23 Stendal V1445/99 1/500 29 27 26 25 25 23 20 22
24 USA 
VD29949/17
1/500 31 29 26 26 27 25 22 24
25 USA 2 1/500 29 27 24 No Cq 24 22 19 21
26 Neg. RNA No Cq No Cq No Cq No Cq No Cq No Cq No Cq No Cq
27 Neg. RNA 42† No Cq No Cq No Cq 35 No Cq No Cq No Cq
28 RSB 50 No Cq No Cq No Cq No Cq No Cq No Cq No Cq No Cq
In-house assay
 Kleiboeker
Kleiboeker 
(mod-1)
Kleiboeker 
(mod-2) Egli
Balka 
(mod-1)
Balka 
(mod-2)
Revilla-
Fernández
Suárez/Oleksiewicz 
(mod)
 EU+NA EU+NA EU+NA EU+NA Pan Pan EU+NA Pan
 1 Stendal V953 1.00E-02 26 28 18 No Cq 33 35 27 24
 2 Stendal V953 1.00E-03 29 32 22 No Cq 37 39 30 27
 3 Stendal V953 1.00E-04 32 34 24 No Cq 41 43 33 30
 4 Stendal V953 1.00E-05 39† 38 No Cq No Cq No Cq No Cq No Cq 35
 5 Stendal V953 1.00E-06 38 No Cq No Cq No Cq No Cq No Cq No Cq No Cq
 6 Stendal V1952/97 1.00E-02 39 26 14 30 30 32 23 24
 7 Stendal V1952/97 1.00E-03 38† 29 18 32 34 35 26 26
 8 Stendal V1952/97 1.00E-04 37† 32 19 No Cq 38 40 30 29
 9 Stendal V1952/97 1.00E-05 42† 35 26 No Cq 42 44 35 32
10 Stendal V1952/97 1.00E-06 37† 40† No Cq No Cq No Cq No Cq No Cq 36
11 Cobbelsdorf 1:500 24 26 13 28 31 33 25 26
12 Stendal V852 1:500 24 26 16 No Cq 31 34 24 28
13 Stendal V1904 1:500 24 27 17 30 32 34 25 25
14 Aus 1/10 No Cq 26 12 21 24 26 22 32
(continued)
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15 Bor 1/10 No Cq 34 20 29 33 34 34 29
16 SZA 1/10 37‡ 24 13 29 26 27 28 21
17 Okt 1/10 No Cq 28 No Cq 31 32 34 34 34
18 China 1.00E-02 24 22 13 25 34 36 30 24
19 China 1.00E-03 27 26 17 31 39 41 35 28
20 China 1.00E-04 31 28 20 No Cq 43 47 38 31
21 China 1.00E-05 35 32 23 No Cq No Cq No Cq No Cq 32
22 China 1.00E-06 39 35 No Cq No Cq No Cq No Cq No Cq No Cq
23 Stendal V1445/99 1/500 25 23 13 23 34 34 28 25
24 USA 
VD29949/17
1/500 26 24 14 23 35 36 28 26
25 USA 2 1/500 23 22 13 24 33 33 27 22
26 Neg. RNA 41 No Cq No Cq No Cq No Cq No Cq No Cq No Cq
27 Neg. RNA No Cq No Cq No Cq No Cq No Cq No Cq No Cq 36
28 RSB 50 41† No Cq No Cq No Cq No Cq No Cq No Cq No Cq
* EU = Europe; NA = North America. False-negative results are depicted in bold; false-positive results are depicted in italic.
† Only 1 of the duplicates scored positive.
‡ Very flat curve.
Table 4. (continued)
by the PRRSV-NA–specific PCR method, and only 1 assay 
produced an EU genotype-positive result incorrectly. When 
investigating the EU-PRRSV samples, the assay published 
previously8 failed to detect 2 of the 5 EU-1 strains integrated 
in the ring trial panel. The other assays scored correctly 
positive, even though differences regarding the analytical 
sensitivity were observed. The 5 log 10 dilution steps of 
strain “Stendal V953” gave a positive result in 3 assays, 4 
assays detected 4 dilution steps correctly, 7 methods gave a 
positive result for 3 dilution steps, and 1 assay detected 
PRRSV RNA in the 2 samples with the highest genome 
amount. The EU-2 strains integrated in the ring trial were 
tested positive by 81.25% and 68.75% of the used assays, 
the EU-3 strain by 93.75%, and the EU-4 strain OKT was 
detected correctly positive by 75.0% of the assays. When 
testing the EU-2 strains, kit I gave a negative result in the 
pan-assay, whereas the genotype-specific assay scored posi-
tive. Every PRRSV-EU strain was classified into the correct 
genotype by the assays used in the ring trial; the solitary 
exception was sample 9 investigated with 1 of the commer-
cial kits.
For further validation of the assays, lung samples were 
tested by the different commercial kits. The results obtained 
with those samples using the pan-PRRSV as well as the 
geno type-specific commercial kits are shown in Table 6. In 
1 sample, the EU genotype was detected consistently, while 
in the 2 other samples containing only EU-PRRSV, 1 kit 
failed to detect the genome. All 4 kits gave a correct positive 
result when investigating the sample containing 
NA-PRRSV, whereas in 1 case (kit IV), an incorrect 
EU-PRRSV–positive result was obtained. Double infection 
with both genotypes in sample “BH 95/10-8” was detected 
by all kits used in the current study; however, kit IV did not 
enable a robust differentiation between infection with both 
genotypes and NA-PRRSV.
Sequencing and phylogenetic analysis
The phylograms (Fig. 1a–c) of the sequences generated in 
the current study compared to the reference strains selected 
from GenBank illustrate the genetic diversity of the PRRSV 
strains used in this ring trial. The European strains can be 
separated into 4 genetic subtypes. When analyzing ORF5 
sequences of the ring trial samples, 5 of the EU genotype 
strains are classified into subtype 1, 2 strains into subtype 2, 
1 strain into subtype 3, and strain “Okt” into subtype 4. The 
isolates “China,” “Stendal V1445/99,” “USA VD29949/17,” 
and “USA 2” were clearly assigned to the NA genotype. The 
classification observed in ORF5 correlates with the phylo-
genetic grouping of ORF6 as well as ORF7 nucleotide 
sequences.
In 1 of the lung samples collected in Germany, the NA 
genotype was detected, 1 further sample contained both gen-
otypes (mixed infection), clearly separated by sequencing, 
In-house assay
 Kleiboeker
Kleiboeker 
(mod-1)
Kleiboeker 
(mod-2) Egli
Balka 
(mod-1)
Balka 
(mod-2)
Revilla-
Fernández
Suárez/Oleksiewicz 
(mod)
 EU+NA EU+NA EU+NA EU+NA Pan Pan EU+NA Pan
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Table 5. Mean quantification cycle (Cq) values of genotype-specific genome detection using commercial reverse transcription 
quantitative polymerase chain reaction kits and in-house assays.* 
Commercial kit
 Kit I Kit II Kit III Kit IV
Sample PRRSV strain Dilution EU NA EU NA EU NA EU NA EU NA NA+EU EU NA+EU EU NA+EU EU
 1 Stendal V953 1.00E-02 27 No Cq 27 No Cq 23 No Cq 27 No Cq 25 No Cq 29 29 27 28 28 29
 2 Stendal V953 1.00E-03 30 No Cq 30 No Cq 27 No Cq 31 No Cq 28 No Cq 33 34 32 32 33 35
 3 Stendal V953 1.00E-04 33 No Cq 33 No Cq 30 No Cq 34 No Cq 32 No Cq 38† No Cq No Cq No Cq 39 No Cq
 4 Stendal V953 1.00E-05 36 No Cq 36 No Cq 33 No Cq No Cq No Cq 36 No Cq No Cq No Cq No Cq No Cq No Cq No Cq
 5 Stendal V953 1.00E-06 39† No Cq 41† No Cq 36† No Cq No Cq No Cq No Cq No Cq No Cq No Cq No Cq No Cq No Cq No Cq
 6 Stendal V1952/97 1.00E-02 25 No Cq 25 No Cq 22 No Cq 25 No Cq 23 No Cq 31 27 27 23 30 24
 7 Stendal V1952/97 1.00E-03 28 No Cq 28 No Cq 25 No Cq 29 No Cq 27 No Cq 34 28 32 26 35 26
 8 Stendal V1952/97 1.00E-04 31 No Cq 32 No Cq 29 No Cq 32 No Cq 30 No Cq No Cq 32 No Cq 29 No Cq 30
 9 Stendal V1952/97 1.00E-05 34 No Cq 35 No Cq 32 No Cq 35 33 33 No Cq No Cq 36 No Cq 33 No Cq 34
10 Stendal V1952/97 1.00E-06 37 No Cq 39 No Cq 35 No Cq 37 No Cq 36 No Cq No Cq No Cq No Cq No Cq No Cq 37
11 Cobbelsdorf 1:500 24 No Cq 27 No Cq 24 No Cq 27 No Cq 26 No Cq 27 26 24 24 26 24
12 Stendal V852 1:500 24 No Cq 27 No Cq 26 No Cq 29 No Cq 27 No Cq 30 28 25 25 29 26
13 Stendal V1904 1:500 25 No Cq 28 No Cq 23 No Cq 27 No Cq 25 No Cq 30 28 27 26 30 27
14 Aus 1/10 29†‡§ No Cq 22 No Cq 34 No Cq No Cq No Cq 33 No Cq 25 22 21 20 24 21
15 Bor 1/10 34†‡§ No Cq 30 No Cq No Cq No Cq No Cq No Cq No Cq No Cq 33 28 30 26 33 27
16 SZA 1/10 No Cq No Cq 27 No Cq 22 No Cq 25 No Cq 23 No Cq 24 25 21 23 23 24
17 Okt 1/10 No Cq No Cq 30 No Cq 36 No Cq No Cq No Cq 36 No Cq 28 26 24 25 28 25
18 China 1.00E-02 No Cq 24 No Cq 28 No Cq 23 No Cq 23 No Cq 24 23 No Cq 21 No Cq 22 No Cq
19 China 1.00E-03 No Cq 29 No Cq 31 No Cq 27 No Cq 27 No Cq 27 27 No Cq 24† No Cq 26 No Cq
20 China 1.00E-04 No Cq 32 No Cq 34 No Cq 30 No Cq 30 No Cq 31 30 No Cq 27 No Cq 29 No Cq
21 China 1.00E-05 No Cq 36 No Cq 38 No Cq 33 No Cq 33 No Cq 33 34 No Cq 31 No Cq 33 No Cq
22 China 1.00E-06 No Cq 39 No Cq No Cq No Cq 36 No Cq 36 No Cq No Cq 37 No Cq 34 No Cq 37 No Cq
23 Stendal V1445/99 1/500 No Cq 26 No Cq 27 No Cq 26 No Cq 25 No Cq 25 23 No Cq 20 No Cq 22 No Cq
24 USA VD29949/17 1/500 No Cq 28 No Cq 29 No Cq 26 No Cq 26 No Cq 27 25 No Cq 22 No Cq 24 No Cq
25 USA 2 1/500 No Cq 26 No Cq 27 No Cq 24 No Cq No Cq No Cq 24 22 No Cq 19 No Cq 21 No Cq
26 Neg. RNA No Cq No Cq No Cq No Cq No Cq No Cq No Cq No Cq No Cq No Cq No Cq No Cq No Cq No Cq No Cq No Cq
27 Neg. RNA No Cq No Cq No Cq No Cq No Cq No Cq No Cq No Cq 35 No Cq No Cq No Cq No Cq No Cq No Cq No Cq
28 RSB 50 No Cq No Cq No Cq No Cq No Cq No Cq No Cq No Cq No Cq No Cq No Cq No Cq No Cq No Cq No Cq No Cq
In-house assay
Kleiboeker Kleiboeker (mod-1)
Kleiboeker 
(mod-2) Egli
Revilla-
Fernández
Suárez/Oleksiewicz 
(mod)
   EU NA EU NA EU NA EU NA EU NA EU NA
 1 Stendal V953 1.00E-02 26 No Cq 28 No Cq 18 No Cq No Cq No Cq 27 No Cq 24 No Cq
 2 Stendal V953 1.00E-03 29 No Cq 32 No Cq 22 No Cq No Cq No Cq 30 No Cq 27 No Cq
 3 Stendal V953 1.00E-04 32 No Cq 34 No Cq 24 No Cq No Cq No Cq 33 No Cq 30 No Cq
 4 Stendal V953 1.00E-05 39† No Cq 38 No Cq No Cq No Cq No Cq No Cq No Cq No Cq 35 No Cq
 5 Stendal V953 1.00E-06 38 No Cq No Cq No Cq No Cq No Cq No Cq No Cq No Cq No Cq No Cq No Cq
 6 Stendal V1952/97 1.00E-02 39 No Cq 26 No Cq 14 No Cq 30 No Cq 23 No Cq 24 No Cq
 7 Stendal V1952/97 1.00E-03 38† No Cq 29 No Cq 18 No Cq 32 No Cq 26 No Cq 26 No Cq
 8 Stendal V1952/97 1.00E-04 37† No Cq 32 No Cq 19 No Cq No Cq No Cq 30 No Cq 29 No Cq
 9 Stendal V1952/97 1.00E-05 42† No Cq 35 No Cq 26 No Cq No Cq No Cq 35 No Cq 32 No Cq
10 Stendal V1952/97 1.00E-06 37† No Cq 40† No Cq No Cq No Cq No Cq No Cq No Cq No Cq 36 No Cq
11 Cobbelsdorf 1:500 24 No Cq 26 No Cq 13 No Cq 28 No Cq 25 No Cq 26 No Cq
12 Stendal V852 1:500 24 No Cq 26 No Cq 16 No Cq No Cq No Cq 24 No Cq 28 No Cq
13 Stendal V1904 1:500 24 No Cq 27 No Cq 17 No Cq 30 No Cq 25 No Cq 25 No Cq
14 Aus 1/10 No Cq No Cq 26 No Cq 12 No Cq 21 No Cq 22 No Cq 32 No Cq
15 Bor 1/10 No Cq No Cq 34 No Cq 20 No Cq 29 No Cq 34 No Cq 29 No Cq
16 SZA 1/10 37† No Cq 24 No Cq 13 No Cq 29 No Cq 28 No Cq 21 No Cq
17 Okt 1/10 No Cq No Cq 28 No Cq No Cq No Cq 31 No Cq 34 No Cq 34 No Cq
18 China 1.00E-02 No Cq 24 No Cq 22 No Cq 13 No Cq 25 No Cq 30 No Cq 24
19 China 1.00E-03 No Cq 27 No Cq 26 No Cq 17 No Cq 31 No Cq 35 No Cq 28
20 China 1.00E-04 No Cq 31 No Cq 28 No Cq 20 No Cq No Cq No Cq 38 No Cq 31
21 China 1.00E-05 38 35 No Cq 32 No Cq 23 No Cq No Cq No Cq No Cq No Cq 32
22 China 1.00E-06 No Cq 39 No Cq 35 No Cq No Cq No Cq No Cq No Cq No Cq No Cq No Cq
23 Stendal V1445/99 1/500 No Cq 25 No Cq 23 No Cq 13 No Cq 23 No Cq 28 No Cq 25
24 USA VD29949/17 1/500 No Cq 26 No Cq 24 No Cq 14 No Cq 23 No Cq 28 No Cq 26
25 USA 2 1/500 No Cq 23 No Cq 22 No Cq 13 No Cq 24 No Cq 27 No Cq 22
26 Neg. RNA 41 No Cq No Cq No Cq No Cq No Cq No Cq No Cq No Cq No Cq No Cq No Cq
27 Neg. RNA No Cq No Cq No Cq No Cq No Cq No Cq No Cq No Cq No Cq No Cq No Cq 36
28 RSB 50 41† No Cq No Cq No Cq No Cq No Cq No Cq No Cq No Cq No Cq No Cq No Cq
* EU = Europe; NA = North America. False-negative results are depicted in bold; false-positive results are depicted in italic.
† Very flat curve.
‡ Only 1 of the duplicates scored positive.
§ Negative result in the pan–Porcine reproductive and respiratory syndrome virus (PRRSV) polymerase chain reaction, while the genotype-specific assay of the kit gave a positive result.
 at Tech Knowl Center - Inst 5500 on July 26, 2012vdi.sagepub.comDownloaded from 
8 Wernike et al.
Table 6. Identity of lung samples and mean quantification cycle (Cq) values of Porcine reproductive and respiratory syndrome virus 
(PRRSV) genome detection using the commercial reverse transcription quantitative polymerase chain reaction kits.*
Detection results (Cq mean)
 GenBank accession no. Kit I Kit II Kit III Kit IV
Sample Country Year ORF5 ORF6 ORF7
Genotype-
Subtype Pan EU NA EU NA EU NA EU EU+NA
BH 95/10-06 Germany 2010 JN651745 JN651726 JN651707 NA 33 No Cq 33 No Cq 29 No Cq 29 28 26
BH 95/10-08 Germany 2002 JN651746 JN651727 JN651708 NA 27 30 25 37 26 31 27 24 22
 JN651737 JN651718 JN651699 EU-1  
BH 95/10-12 Germany 2006 JN651738 JN651719 JN651700 EU-1 26 25 No Cq No Cq No Cq 25 No Cq 23 28
BH 95/10-13 Germany 2000 JN651739 JN651720 JN651701 EU-1 33 32 No Cq 35 No Cq 32 No Cq 35† No Cq
BH 95/10-14 Germany 2008 JN651740 JN651721 JN651702 EU-1 31 30 No Cq No Cq No Cq 31 No Cq 28 No Cq
* EU = Europe; NA = North America. GenBank accession numbers indicate the sequences generated in the current study.
† Very flat curve.
and in the 3 additional samples, EU-PRRSV was found. 
None of them belonged to the Eastern European subtype.
The similarity of the NA strains to their prototype strain 
“VR2332” ranged between 87% and 97% for complete 
ORF5 sequences, 95% and 99% for ORF6, and 94% and 
100% for ORF7 sequences. The EU strains used are 81–99% 
(ORF5), 86–99% (ORF6), and 83–100% (ORF7) identical to 
their prototype strain “Lelystad.” Major length differences 
were found between the ORF7 of EU-1 isolates, which were 
387 nucleotides (nt), with exception of BH 95/10-12, which 
had a length of 381 nt.
Discussion
To compare the wide range of RT-qPCR systems for PRRSV 
genome detection, a variety of EU and NA strains were sent 
to 7 European laboratories. The presence of PRRSV genome 
was confirmed by sequencing and phylogenetic analysis. A 
total of 4 different commercially available RT-qPCR kits 
and 8 in-house assays were used to analyze the samples. 
Altogether, huge differences were observed between the 
individual RT-qPCR systems. Based on the selected PRRSV 
strains used in the ring trial, no assay or commercial kit could 
be identified with optimal analytical and diagnostic sensitiv-
ity. In general, inconsistencies were mainly observed in the 
detection of the EU genotypes compared to the PRRSV-NA 
strain–specific sequences. This observation could be 
explained by the large genetic diversity of the viruses within 
the EU genotype.7,25,32 Atypically diverse EU genotype 
PRRSV strains have been reported in several European 
countries,18 for instance in Denmark,24 Spain,7 Germany, and 
the Netherlands,25 as well as in Italy.9 The global dissemina-
tion of pan-European subtype 1 is assumed, as strains classi-
fied into this subtype have been recently reported in Asian 
countries such as China,5 Korea,21 and Thailand.37 Subtypes 
2, 3, and 4, whose existence was solely reported from Eastern 
Europe so far, exceed the diversity of subtype 1.15,30,31 Four 
of the Eastern European, non–EU-1 strains were integrated 
in the ring trial, and these strains caused major difficulties 
concerning molecular detection. The strain “Bor,” for exam-
ple, was only detected by 68.75% of the RT-qPCR assays.
Contrary to the EU strains, the NA strains used in the 
current study were rather similar. As a result, the actual per-
formance capability of the qPCR assays regarding NA strains 
is not reflected in its entirety.
Analytical sensitivity of the applied assays varied in a 
range of up to 3 log 10 dilution steps for the NA as well as 
for the EU strains. However, an insufficient diagnostic sen-
sitivity has to be assessed more critically than a reduced ana-
lytical sensitivity. In summary, commercial kit II and the 
in-house assay using a combination of a modified published 
assay17 and an additional PRRSV-EU assay based on ORF6 
(modification 1) revealed the best results when investigating 
the virus strains sent to the participating laboratories. 
However, commercial kit II failed to correctly detect 2 of the 
strains isolated from German lung samples. In contrast, the 
Kleiboeker-modification 1 assay had no problems detecting 
these strains (data not shown).
Similar to the current study, in a ring trial conducted in 
Germany,36 false-negative results were found to be the most 
common pitfall of the RT-PCR assays used. The presence of 
inhibitors within the reaction, not fully optimized PCR sys-
tems, unsuited primer sequences, and not standardized RNA 
preparation methods were suspected to be responsible for 
this observation. The latter can be excluded in the current 
Europe-wide ring trial because identical RNA samples were 
sent to the participating laboratories. To ensure adequate 
extraction of nucleic acids, especially when using potentially 
difficult biological matrices, as well as to confirm the 
absence of PCR inhibiting factors, the coamplification of an 
internal control is a valuable tool.3,13
To avoid mismatches in the primer and probe binding 
sites, the sequences should be controlled continuously by 
sequence analysis of emerging strains. In addition to ORF5, 
whose sequences were commonly used for phylogenetic 
analysis, sequencing of ORF6 and 7 was conducted, because 
most of the RT-qPCR assays used in the ring trial target this 
genomic region (see Table 2). Phylogenetic grouping of 
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Figure 1. Phylogenetic analysis of ring trial samples and reference strains based on nucleotide sequences of open reading frame (ORF)5 
(A), ORF6 (B), and ORF7 (C). Each isolate is indicated by virus name; ring trial samples are depicted in red. Statistical support for nodes 
was obtained by bootstrapping (1,000 replicates); only values ≥50% are shown. Scale bar indicates the estimated number of nucleotide 
substitutions per site. Sequence identity of the ring trial samples to their respective prototype strain is depicted in parentheses. The prototype 
strains are Lelystad for Europe (EU) and VR-2332 for North America (NA) genotype (both are marked by asterisk).
ORF5, 6, and 7 showed a good correlation for the selected 
strains. In agreement with previous studies,30,31 the division 
of EU isolates into 4 subtypes is observed in ORF5 and 7 
phylograms. In the ORF6 phylogenetic tree, subtype 1 iso-
lates can be separated from other subtypes, and further divi-
sion is not possible due to the lack of ORF6 sequence 
information of additional Eastern European strains.
For EU isolates, concordance between the size of ORF7 
and the phylogenetic grouping has been reported31; subtype 
1 contained viruses with an ORF7 size of 387 nt. However, 1 
of the lung samples collected in Germany, which clearly 
could be classified as subtype 1, exhibited an ORF7 
containing only 381 nt, thus size polymorphism is observed 
within subtype 1. Consequently, for subtyping of EU 
PRRSV isolates, the sequence analysis is most suitable. 
Furthermore, sequencing is essential to notice mismatches in 
the primer and probe binding sites. However, identity of the 
complete ORF sequences of the used strains to their respec-
tive prototype strain did not correlate in full with the real-
time PCR detection results. As an example, lung sample 
“BH 95/10-14” with an identity of 99% (ORF6, 7) and 97% 
(ORF5), respectively, to “Lelystad” was not detected by 1 of 
the commercial kits. The same result was obtained when 
investigating subtype 3 strain “SZA,” whose identity to the 
Figure 1. (continued)
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EU prototype strain ranged between 83% and 86% for the 
sequenced ORFs 5, 6, and 7. This observation emphasizes 
the importance of the combined application of several, inde-
pendent real-time detection systems, which is possible either 
by usage of different assays or kits or by combination of 2 or 
more qPCR systems within a single multiplex reaction. The 
latter is realized in the Kleiboeker-modification 1 assay. For 
the detection of EU genotype strains, 2 systems are used that 
target ORFs 6 and 7 sequences, respectively.
In 1 of the samples isolated from lung material, EU and 
NA genotype PRRSV was independently detected by 3 com-
mercial kits and confirmed by sequencing. In Europe, coex-
istence of both genotypes within the same swine herd has 
been documented.10,23 The EU genotype PRRSV isolates 
have been introduced into North American swine herds28 as 
well. To investigate the spread of both genotypes, the clas-
sification of new isolates is highly recommended.
Genotyping was possible by most of the RT-qPCR assays 
used in the ring trial, either in 2 separated or in a single mul-
tiplex reaction. Multiplex approaches, where 2 or more tar-
gets are amplified in the same tube and detected in parallel,39 
enable cost-effective and fast answers to several diagnostic 
questions11 (e.g., in the case of PRRSV, the detection and 
genotyping of a sample in a single reaction). The selected 
PRRSV strains used in the ring trial were correctly assigned 
to the appropriate genotype by almost all assays. However, 
kit IV is, in contrast to manufacturer’s information, not use-
ful for genotyping. Based on the fact that one probe is spe-
cific for EU and another for EU and NA, a differentiation 
between a double infection with both genotypes and 
NA-PRRSV is not possible. As an example, the lung sample 
“BH 95/10-08” would not have been found as being double 
infected, as the results of the other kits and the sequencing of 
the sample had suggested. But on the other hand, PRRSV 
genome was detected in every lung sample by this kit, even 
though genotyping is not possible. In contrast, 2 out of 5 of 
these lung samples were tested negative by kit II. This obser-
vation emphasizes that the greatest problem in PRRSV 
genome detection is the false-negative results. Because of 
the great genetic diversity of PRRSV strains, even affecting 
binding sites for diagnostic primers and probes, the com-
bined usage of different assays or kits is highly recom-
mended to achieve a maximum of diagnostic safety.
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